In 1983 Eli Lilly and American company prepared two DNA sequences corresponding to A and B, chains of human insulin, introduced them in plasmids of E.coli to produce insulin chains. Chains A and B were produced separately extracted and combined by creating disulfide bonds to form human insulin.